06628.HK
Transcenta Holding Limited
HKSE · Healthcare · Biotechnology · CN
HKD 0.98
+17.47%Next report
Analyst consensus
- Next report date
- Mar 31, 2027
- EPS estimate
- -HKD 0.55
- Revenue estimate
- HKD 92.6M
Latest reported
- Last report date
- Aug 28, 2026
- EPS actual
- -HKD 0.19
- EPS estimate
- -HKD 0.53
- Revenue actual
- HKD 27.5M
- Revenue estimate
- HKD 29.5M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +64.5%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 28, 2026 | -HKD 0.53 | -HKD 0.19 | Beat 64.48% | HKD 27.5M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 31, 2027